ClinicalTrials.Veeva

Menu
P

Pontificia Universidad Catolica de Chile | Centro de Investigacion Clinica UC-CICUC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Atezolizumab
Nivolumab
Pembrolizumab
UDCA
Seralutinib
BMS-986012
Deucravacitinib
BMS-986489
Paclitaxel
Doxorubicin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 51 total trials

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella B)

This is an open-label, multicenter, extension study. Patients who are receiving clinical benefit from atezolizumab monotherapy or atezolizumab in com...

Active, not recruiting
Cancer
Drug: Emactuzumab
Drug: Niraparib

The aim of this study is to assess the safety and tolerability of BMS-986360 as monotherapy and in combination with chemotherapy or nivolumab in part...

Active, not recruiting
Advanced Solid Tumors
Drug: Capecitabine
Drug: Docetaxel

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with...

Enrolling
Extensive-Stage Small Cell Lung Cancer
Drug: Carboplatin
Drug: Etoposide

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy...

Enrolling
Non-small Cell Lung Cancer
Drug: Relatlimab
Drug: Nivolumab

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

This is a placebo-controlled study to evaluate the addition of CAL02 to standard of care in treating hospitalized subjects diagnosed with severe comm...

Enrolling
Pneumonia, Bacterial
Drug: CAL02
Drug: Placebo

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Seralutinib

The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat compared to sunitinib or pazopanib in participant...

Active, not recruiting
Renal Cell Carcinoma (RCC)
Drug: Pazopanib
Drug: Epacadostat

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with platinum based therapy...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Trial sponsors

P
Bristol-Myers Squibb (BMS) logo
Pfizer logo
Roche logo
A
A
Boston Scientific logo
Columbia University logo
CymaBay Therapeutics logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems